Premium
Use of point‐of‐care testing for plasma therapy
Author(s) -
Goodnough Lawrence Tim,
Hill Charles C.
Publication year - 2012
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/j.1537-2995.2012.03624.x
Subject(s) - point of care testing , medicine , intensive care medicine , point of care , blood component , fresh frozen plasma , medical emergency , pathology , platelet
Use of point‐of‐care testing (POCT) has been driven by limitations of laboratory‐based testing as a tool for decisions for transfusions of blood components. Clinical settings such as liver transplantation, cardiothoracic surgery, and trauma are particularly in need of such diagnostic tests because of the complex coagulopathies that can develop in these settings of substantial hemorrhage and need for blood component support. Successful implementation of POCT requires collaboration between surgery, anesthesia, critical care, and the laboratory to ensure proper quality control of equipment, operator training and competency, medical records test results, billing procedures, and consensus‐derived transfusion algorithms for cost‐effective, targeted blood component transfusion support. In this review we summarize clinical evidence for the effectiveness of POCT, along with some future directions for this strategy.